Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer - PowerPoint PPT Presentation

1 / 20
} ?>
View by Category
About This Presentation
Title:

Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer

Description:

Phase II trial of the oral PARP inhibitor olaparib (AZD2281) in BRCA-deficient advanced ovarian cancer MW Audeh,1 RT Penson,2 M Friedlander,3 B Powell,4 – PowerPoint PPT presentation

Number of Views:207
Avg rating:3.0/5.0
Slides: 21
Provided by: SonyU151
Category:

less

Write a Comment
User Comments (0)
About PowerShow.com